Trends and outcomes of hospitalizations for peptic ulcer disease in the united states, 1993 to 2006

Annals of Surgery

Volumn 251, Issue 1, 2010, Pages 51-58

  Wang, Y Richard ^a,b   Richter, Joel E ^a   Dempsey, Daniel T ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE SEVERITY; DUODENUM ULCER; ENDOSCOPY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTRECTOMY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PREVALENCE; PRIORITY JOURNAL; STOMACH ULCER; SURGICAL TECHNIQUE; TREND STUDY; ULCER PERFORATION; UNITED STATES; VAGOTOMY; APPENDICITIS; CHOLECYSTITIS; MIDDLE AGED; RISK FACTOR; TREATMENT OUTCOME;

AGED; APPENDICITIS; CHOLECYSTITIS; DUODENAL ULCER; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; RISK FACTORS; STOMACH ULCER; TREATMENT OUTCOME; UNITED STATES;

EID: 74049142845     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b975b8     Document Type: Article

References (28)

1. Soll AH. Medical treatment of peptic ulcer disease. JAMA. 1996;275:622-629.
2. Munnangi S, Sonnenberg A. Time trends of physician visits and treatment patterns of peptic ulcer disease in the United States. Arch Intern Med. 1997;157:1489-1494.
3. Lewis JD, Bilker WB, Brensinger C, et al. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of non-steroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol. 2002;97:2540-2549.
4. Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med. 1998;338:719-726.
5. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000;343:310-316.
6. Barkun A, Sabbah S, Enns R, et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): endoscopic he-mostatis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol. 2004;99:1238-1246.
7. Lau JY, Leung WK, Wu JC, et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med. 2007;356:1631-1640
8. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. JAMA. 1994;272:65-69.
9. Brock J, Sauaia A, Ahnen D, et al. Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease: results from a quality improvement project. JAMA. 2001;286:1985-1993.
10. Lau JY, Sung JJ, Lam YH, et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med. 1999;340:751-756.
11. Marmo R, Rotondano G, Piscopo, et al. dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol. 2007;102:279-289.
12. Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl J Med. 2008;359:928-937.
13. Simeone DM, Hassan A, Scheiman JM. Giant peptic ulcer: a surgical or medical disease? Surgery. 1999;126:474-478.
14. Schwesinger WH, Page CP, Sirinek KR, et al. Operations for peptic ulcer disease: paradigm lost. J Gastrointest Surg. 2001;5:438-443.
15. Paimela H, Paimela L, Myllykangas-Luosujarvi R, et al. Current features of peptic ulcer disease in Finland: incidence of surgery, hospital admissions and mortality for the disease during the past twenty-five years. Scand J Gastro-enterol. 2002;37:399-403.
16. Towfigh S, Chandler C, Hines OJ, et al. Outcomes from peptic ulcer surgery have not benefited from advances in medical therapy. Am Surg. 2002;68:385-389.
17. Espat NJ, Ong ES, Helton WS, et al. 1990-2001 US general surgery chief resident gastric surgery operative experience: analysis of paradigm shift. J Gastrointest Surg. 2004;8:471-478.
18. Paimela H, Oksala NKH, Kivilaakso E. Surgery for peptic ulcer today. Dig Surg. 2004;21:185-191.
19. Targownik LE, Nabalamba A. Trends in management and outcomes of acute nonvariceal upper gastrointestinal bleeding: 1993-2003. Clin Gastroenterol Hepatol. 2006;4:1459-1466.
20. Sarosi GA, Jaiswal KR, Nwariaku FE, et al. Surgical therapy of peptic ulcers in the 21st century: more common than you think. Am J Surg. 2005;190:775-779.
21. Lipof T, Shapiro D, Kozol RA. Surgical perspectives in peptic ulcer disease and gastritis. World J Gastroenterol. 2006;12:3248-3252.
22. HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality; 1993-2006.
23. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45: 613-619.
24. Gilliam AD, Speake WJ, Lobo DN, et al. Current practice of emergency vagotomy and Helicobacter pylori eradication for complicated peptic ulcer in the United Kingdom. Br J Surg. 2003;90:88-90.
25. Harbison SP, Dempsey DT. Peptic ulcer disease. Curr Probl Surg. 2005;42: 346-454.
26. Cram P, Hillis SL, Barnett M, et al. Effects of weekend admission and hospital teaching status on in-hospital mortality. Am J Med. 2004;117:151-157. (Pubitemid 39055865)
27. Bell CM, Redelmeier DA. Mortality among patients admitted to hospitals on weekends as compared with weekdays. N Engl J Med. 2001;345:663-668.
28. Schmulewitz L, Proudfoot A, Bell D. The impact of weekends on outcome for emergency patients. Clin Med. 2005;5:621-625.